We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Approves Expanded Indication for Velcade
FDA Approves Expanded Indication for Velcade
June 27, 2008
The FDA approved an expanded indication last week for Millennium Pharmaceuticals’ cancer drug Velcade, which is now indicated as a first-line treatment for multiple myeloma.